Skip to main content
. 2024 May 23;31(6):388–400. doi: 10.1159/000538938

Table 4.

Disease-related complications of short bowel syndrome/intestinal failure

Complication Pathophysiology Management Prevention
Intestinal failure liver disease (IFALD) • Multifactorial condition (sepsis, intestinal anatomy, oral nutrition/EN, PN infusion modality, nutrition deficiency or excess) • Reduce the total lipid amount and/or decrease omega-6/omega-3 PUFA ratio • Identify/treat sepsis
• Soybean-lipid emulsions in excess • Revise potential inflammatory/infectious foci • Identify/treat sepsis
• Steatosis (adults) • No evidence to recommend lipid-free regimens, as well as the use of ursodeoxycholic acid, choline, taurine, or carnitine • Preserve small intestine length and colon in continuity
• Hepatocellular injury or cholestasis (children) • Increase oral/enteral intake
• Cycled PN with soybean oil-based lipid content less than 1 g/kg/day
Gallbladder sludge and stones • Negligible oral intake • Endoscopic/surgical procedures as for the general population • Preserve small intestine length and colon in continuity
• Intestinal remnant length less than 180 cm • Increase oral/enteral intake • Increase oral/enteral intake
• Crohn’s disease
Kidney disease and stones • Chronic dehydration (kidney disease) • Management as for the general population • Monitor fluid balance and renal function*
• Increased absorption of oxalate, hypovolemia, hypomagnesemia and metabolic acidosis (kidney stones) • Low-fat and low-oxalate diet*
• Calcium carbonate and potassium citrate supplementation*
Bone disease • Toxicity from aluminum contamination of the nutrition formula • Supplement calcium and vitamin D as needed • Correct metabolic acidosis when present
• Increased sensitivity to vitamin D suppressing PTH secretion • Periodic assessment of bone mineral density, calcium, magnesium, vitamin D and supplement as needed
• Hypercalciuria
• Micronutrient deficiency (vitamin C and copper)
• Vitamin A toxicity

EN, enteral nutrition; PN, parenteral nutrition; PUFA, poly-unsaturated fatty acid.

*Especially in patients with colon in continuity.